
[Federal Register Volume 77, Number 126 (Friday, June 29, 2012)]
[Notices]
[Page 38838]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15907]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-D-0558]


Compliance Policy Guide Sec. 230.110--Registration of Blood 
Banks, Other Firms Collecting, Manufacturing, Preparing, or Processing 
Human Blood or Blood Products; Withdrawal

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; withdrawal.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
withdrawal of the compliance policy guide (CPG) entitled ``Sec. 230.110 
Registration of Blood Banks, Other Firms Collecting, Manufacturing, 
Preparing, or Processing Human Blood or Blood Products (CPG 7134.01),'' 
dated June 17, 1974.

DATES: The withdrawal is effective June 29, 2012.

FOR FURTHER INFORMATION CONTACT: Robert L. Hummel, Division of 
Compliance Policy (HFC-230), Food and Drug Administration, 12420 
Parklawn Dr., ELEM-4152, Rockville, MD 20857, 301-796-4510.

SUPPLEMENTARY INFORMATION: FDA issued the CPG entitled ``Sec. 230.110 
Registration of Blood Banks, Other Firms Collecting, Manufacturing, 
Preparing, or Processing Human Blood or Blood Products (CPG 7134.01)'' 
on June 17, 1974. We originally issued CPG 7134.01 entitled 
``Establishment Registration and Product Listing for Manufacturers of 
Human Blood and Blood Products,'' to provide FDA's current thinking 
regarding the registration required by 21 CFR part 607 of blood banks 
and other establishments collecting, manufacturing, preparing, or 
processing human blood or blood products. Since the last update to CPG 
7134.01 in 2000, the regulations for blood establishment registration 
under part 607 have been amended several times. FDA is withdrawing CPG 
7134.01 because it is obsolete.

    Dated: June 13, 2012.
Dara Corrigan,
Associate Commissioner for Regulatory Affairs.
[FR Doc. 2012-15907 Filed 6-26-12; 4:15 pm]
BILLING CODE 4160-01-P


